About MediPines

MediPines is a pioneering medical technology company headquartered in California, focused on transforming respiratory and cardiovascular assessment through non-invasive innovation. Our flagship product, the AGM100, is an FDA-cleared device that delivers real-time insights into a patient’s cardiorespiratory status—including oxygenation, ventilation, and gas exchange efficiency—without requiring invasive procedures.

Key Advancements

• Non-Invasive Point-of-Care Assessment
  The AGM100 enables fast, breath-based evaluation of gas exchange efficiency at the bedside or outpatient setting, delivering clinically actionable parameters in under two minutes.
• Clinically Validated Accuracy
  Benchmarked against arterial blood gas (ABG) testing and supported by peer-reviewed research, the device offers high reliability and utility across emergency and respiratory care settings.
• Regulatory and Reimbursement Milestones
  AGM100 has received FDA 510(k) clearance and was assigned a new CPT code by the American Medical Association. It is also recognized by the World Health Organization as an innovative technology with potential global impact.
• U.S. Manufacturing and Compliance
  MediPines products are designed in California and manufactured entirely within the United States, including through qualified contract manufacturers. All manufacturing activities are conducted in compliance with MDSAP/ISO 13485 requirements, ensuring adherence to globally recognized medical device quality standards. In addition, our U.S.-based production meets Trade Agreements Act (TAA) requirements, enabling eligibility for federal procurement and supporting supply chain resilience.

Our Mission

We aim to empower healthcare professionals with an advanced, easy-to-use assessment system that bring clarity to complex respiratory physiology. By enabling faster, more precise diagnostic and treatment decisions, we support improved patient outcomes across emergency, acute, and chronic care environments.

Global Impact

MediPines technology is currently in use across hospitals and outpatient clinics in North America, with growing global interest. The company is poised to expand internationally, addressing critical needs in emergency medicine, pulmonology, cardiology, and other high-acuity care areas. Its scalable, non-invasive platform delivers meaningful clinical insights across diverse healthcare settings, from acute triage to chronic disease management.

MediPines Team

MediPines is led by a multidisciplinary team of engineers, healthcare experts, and internationally recognized leaders in respiratory science, all committed to advancing respiratory and cardiovascular medicine. With backgrounds spanning respiratory physiology, aerospace engineering, advanced sensors and algorithms, clinical research, and healthcare analytics, the leadership team brings deep technical expertise and operational experience. Together, they have guided the development, regulatory clearance, and early clinical adoption of the AGM100, united by a focus on improving patient outcomes through meaningful innovation.